Back to Search
Start Over
Supplementary Data from Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary data - revised
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3cee480ac1ee5f0a60ca406c3be2c3bc
- Full Text :
- https://doi.org/10.1158/1078-0432.22473104